BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38529392)

  • 1. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
    Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
    Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
    Feelders RA; Nieman LK
    Pituitary; 2022 Oct; 25(5):746-749. PubMed ID: 35881275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
    van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
    Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
    Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
    Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
    Isand K; Feelders R; Brue T; Toth M; Deutschbein T; Reincke M; Kršek M; Santos A; Demtröder F; Chabre O; Strasburger CJ; Aulinas Maso A; Volke V; Pereira AM; Lohmann R; Gich Saladich I; ; Webb SM; Wass J; Valassi E
    Eur J Endocrinol; 2024 Jan; 190(1):75-85. PubMed ID: 38146835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulable state in Cushing's syndrome: a systematic review.
    Van Zaane B; Nur E; Squizzato A; Dekkers OM; Twickler MT; Fliers E; Gerdes VE; Büller HR; Brandjes DP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2743-50. PubMed ID: 19454584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.
    Koutroumpi S; Daidone V; Sartori MT; Cattini MG; Albiger NM; Occhi G; Ferasin S; Frigo A; Mantero F; Casonato A; Scaroni C
    Pituitary; 2013 Jun; 16(2):175-81. PubMed ID: 22585010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism.
    Liew NC; Alemany GV; Angchaisuksiri P; Bang SM; Choi G; DE Silva DA; Hong JM; Lee L; Li YJ; Rajamoney GN; Suviraj J; Tan TC; Tse E; Teo LT; Visperas J; Wong RS; Lee LH
    Int Angiol; 2017 Feb; 36(1):1-20. PubMed ID: 27606807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
    Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
    Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
    Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
    Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New paradigms in venous thromboprophylaxis of medically ill patients.
    Spyropoulos AC; Raskob GE
    Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
    Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
    van der Pas R; Leebeek FW; Hofland LJ; de Herder WW; Feelders RA
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):481-8. PubMed ID: 23134530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex matters: Practice 5P's when treating young women with venous thromboembolism.
    Bistervels IM; Scheres LJJ; Hamulyák EN; Middeldorp S
    J Thromb Haemost; 2019 Sep; 17(9):1417-1429. PubMed ID: 31220399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study.
    Paciullo F; Bury L; Noris P; Falcinelli E; Melazzini F; Orsini S; Zaninetti C; Abdul-Kadir R; Obeng-Tuudah D; Heller PG; Glembotsky AC; Fabris F; Rivera J; Lozano ML; Butta N; Favier R; Cid AR; Fouassier M; Podda GM; Santoro C; Grandone E; Henskens Y; Nurden P; Zieger B; Cuker A; Devreese K; Tosetto A; De Candia E; Dupuis A; Miyazaki K; Othman M; Gresele P
    Haematologica; 2020 Jul; 105(7):1948-1956. PubMed ID: 31558677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study.
    Dargaud Y; Rugeri L; Fleury C; Battie C; Gaucherand P; Huissoud C; Rudigoz RC; Desmurs-Clavel H; Ninet J; Trzeciak MC
    J Thromb Haemost; 2017 May; 15(5):897-906. PubMed ID: 28231636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.